Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Health Economics and Clinical Epidemiology, University Hospital of Cologne, Cologne, Germany.
Crit Care Med. 2020 Dec;48(12):1862-1870. doi: 10.1097/CCM.0000000000004617.
Fluid administration in combination with the increase in vasopermeability induced by critical illness often results in significant fluid overload in critically ill patients. Recent research indicates that mortality is increased in patients who have received large volumes of fluids. We have systematically reviewed and synthesized the evidence on fluid overload and mortality in critically ill patients and have performed a meta-analysis of available data from observational studies.
A systematic search was performed on PubMed, EmBase, and the Cochrane Library databases.
All studies were eligible that investigated the impact of fluid overload (defined by weight gain > 5%) or positive cumulative fluid balance on mortality in adult critical care patients. We excluded animal studies and trials in pediatric populations (age < 16 years old), pregnant women, noncritically ill patients, very specific subpopulations of critically ill patients, and on early goal-directed therapy. Randomized controlled trials were only evaluated in the section on systematic review. Assessment followed the Cochrane/meta-analysis of observational trials in epidemiology guidelines for systematic reviews.
A total of 31 observational and three randomized controlled trials including 31,076 ICU patients met the inclusion criteria. Only observational studies were included in the meta-analysis. Fluid overload and cumulative fluid balance were both associated with pooled mortality: after 3 days of ICU stay, adjusted relative risk for fluid overload was 8.83 (95% CI, 4.03-19.33), and for cumulative fluid balance 2.15 (95% CI, 1.51-3.07), at any time point, adjusted relative risk for fluid overload was 2.79 (95% CI, 1.55-5.00) and 1.39 (95% CI, 1.15-1.69) for cumulative fluid balance. Fluid overload was associated with mortality in patients with both acute kidney injury (adjusted relative risk, 2.38; 95% CI, 1.75-2.98) and surgery (adjusted relative risk, 6.17; 95% CI, 4.81-7.97). Cumulative fluid balance was linked to mortality in patients with sepsis (adjusted relative risk, 1.66; 95% CI, 1.39-1.98), acute kidney injury (adjusted relative risk, 2.63; 95% CI, 1.30-5.30), and respiratory failure (adjusted relative risk, 1.19; 95% CI, 1.03-1.43). The risk of mortality increased by a factor of 1.19 (95% CI, 1.11-1.28) per liter increase in positive fluid balance.
This systematic review and meta-analysis of observational studies reporting adjusted risk estimates suggests that fluid overload and positive cumulative fluid balance are associated with increased mortality in a general population and defined subgroups of critically ill patients.
危重病患者常因液体输注联合血管通透性增加而导致明显的液体超负荷。最近的研究表明,接受大量液体的患者死亡率增加。我们系统地回顾和综合了关于危重病患者液体超负荷和死亡率的证据,并对来自观察性研究的可用数据进行了荟萃分析。
在 PubMed、EmBase 和 Cochrane 图书馆数据库中进行了系统搜索。
所有研究均符合纳入标准,这些研究调查了液体超负荷(体重增加>5%)或正性累积液体平衡对成人重症监护患者死亡率的影响。我们排除了动物研究和儿科人群(年龄<16 岁)、孕妇、非重症患者、重症患者的非常特定亚组以及早期目标导向治疗的研究。随机对照试验仅在系统评价部分进行评估。评估遵循 Cochrane/meta 分析观察性试验在系统评价中的指南。
共有 31 项观察性研究和 3 项随机对照试验纳入了 31076 例 ICU 患者,符合纳入标准。荟萃分析仅纳入观察性研究。液体超负荷和累积液体平衡均与总体死亡率相关:在 ICU 入住 3 天后,液体超负荷的调整后相对风险为 8.83(95%CI,4.03-19.33),累积液体平衡为 2.15(95%CI,1.51-3.07),任何时间点,液体超负荷的调整后相对风险为 2.79(95%CI,1.55-5.00)和 1.39(95%CI,1.15-1.69)对于累积液体平衡。液体超负荷与急性肾损伤(调整后相对风险,2.38;95%CI,1.75-2.98)和手术(调整后相对风险,6.17;95%CI,4.81-7.97)患者的死亡率相关。累积液体平衡与脓毒症(调整后相对风险,1.66;95%CI,1.39-1.98)、急性肾损伤(调整后相对风险,2.63;95%CI,1.30-5.30)和呼吸衰竭(调整后相对风险,1.19;95%CI,1.03-1.43)患者的死亡率相关。正性液体平衡每增加 1 升,死亡率增加 1.19(95%CI,1.11-1.28)。
本系统评价和荟萃分析报告了调整风险估计的观察性研究表明,液体超负荷和正性累积液体平衡与一般人群和危重病患者特定亚组的死亡率增加相关。